Black Rock Inc. Agile Therapeutics Inc Transaction History

Black Rock Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.21 - $0.31 $60 - $89	-290 Reduced 0.1%	303,139 $66,000
Q4 2022 Feb 13, 2023	SELL	$0.18 - $15.25 $66 - $5,642	-370 Reduced 0.12%	303,429 $69,000
Q3 2022 Nov 14, 2022	BUY	$0.28 - $14.85 $71,743 - $3.8 Million	256,227 Added 538.61%	303,799 $91,000
Q2 2022 Aug 12, 2022	BUY	$1.09 - $8.24 $51,853 - $391,993	47,572 New	47,572 $56,000

Ticker AGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 39,023,000
Description
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line exte...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.